Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EEA
5251
European Equity Fund
EEA
$74.1M
| $654K | ﹤0.01% |
63,524
-2,148
| -3% | -$23.1K |
|
5252
GH Research
GHRS
$1.9B
| $653K | ﹤0.01% |
51,404
+47,162
| +1,112% | +$642K |
|
5253
First Trust Exchange-Traded Fund VI First Trust BuyWrite Income ETF
FTHI
$2.39B
| $652K | ﹤0.01% |
27,623
-1
| -0% | -$24 |
|
5254
Virtus Biotech Clinical Trials ETF
BBC
$47.3M
| $650K | ﹤0.01% |
16,859
+6,119
| +57% | +$208K |
|
|
STXF
5255
Strive 500 ETF
STXF
$1.11B
| $650K | ﹤0.01% |
14,740
+1
| +0% | +$44 |
|
|
AIRO
5256
AIRO Group Holdings
AIRO
$223M
| $644K | ﹤0.01% |
78,763
+50,681
| +180% | +$653K |
|
5257
loanDepot
LDI
$541M
| $644K | ﹤0.01% |
311,123
-85,624
| -22% | -$238K |
|
5258
ProShares Short Financials
SEF
$13.2M
| $644K | ﹤0.01% |
20,976
+20,975
| +2,097,500% | +$667K |
|
5259
Taylor Devices
TAYD
$178M
| $644K | ﹤0.01% |
11,011
+1,506
| +16% | +$73K |
|
|
IAF
5260
abrdn Australia Equity Fund
IAF
$120M
| $643K | ﹤0.01% |
49,804
-10,121
| -17% | -$134K |
|
5261
Invesco S&P SmallCap Financials ETF
PSCF
$27.5M
| $643K | ﹤0.01% |
11,188
+1,604
| +17% | +$90.8K |
|
5262
WBI Power Factor High Dividend ETF
WBIY
$63.2M
| $643K | ﹤0.01% |
20,085
+716
| +4% | +$22.4K |
|
5263
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
$323M
| $642K | ﹤0.01% |
25,777
+487
| +2% | +$12.3K |
|
5264
Kewaunee Scientific
KEQU
$102M
| $641K | ﹤0.01% |
17,134
-1,018
| -6% | -$41.4K |
|
5265
Satellogic
SATL
$525M
| $639K | ﹤0.01% |
341,544
+87,117
| +34% | +$188K |
|
5266
Avantis Responsible US Equity ETF
AVSU
$469M
| $639K | ﹤0.01% |
8,369
+4,305
| +106% | +$322K |
|
5267
CF Bankshares
CFBK
$221M
| $638K | ﹤0.01% |
25,553
+6,326
| +33% | +$151K |
|
5268
Air T
AIRT
$73.1M
| $634K | ﹤0.01% |
33,206
+7,700
| +30% | +$163K |
|
5269
NEOS S&P 500 High Income ETF
SPYI
$10.7B
| $634K | ﹤0.01% |
12,061
+5,334
| +79% | +$280K |
|
|
PXED
5270
Phoenix Education Partners
PXED
$1.08B
| $633K | ﹤0.01% |
+20,889
| New | +$700K |
|
5271
Ocugen
OCGN
$427M
| $626K | ﹤0.01% |
463,454
+172,890
| +60% | +$246K |
|
5272
First Capital
FCAP
$211M
| $625K | ﹤0.01% |
10,561
+1,111
| +12% | +$54.9K |
|
|
SMC
5273
Summit Midstream
SMC
$412M
| $624K | ﹤0.01% |
23,388
-22,322
| -49% | -$531K |
|
5274
Western New England Bancorp
WNEB
$290M
| $624K | ﹤0.01% |
49,442
-46,091
| -48% | -$554K |
|
5275
Biote Corp
BTMD
$70.7M
| $623K | ﹤0.01% |
239,736
+56,841
| +31% | +$155K |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.